Heike Pohla

3.6k total citations
67 papers, 2.2k citations indexed

About

Heike Pohla is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Heike Pohla has authored 67 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 33 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Heike Pohla's work include Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (15 papers). Heike Pohla is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (22 papers) and CAR-T cell therapy research (15 papers). Heike Pohla collaborates with scholars based in Germany, United States and Austria. Heike Pohla's co-authors include Dolores J. Schendel, Alexander Büchner, Bernhard Frankenberger, Rainer Riesenberg, Medi Adibzadeh, R. Oberneder, Erko Stackebrandt, A. Hofstetter, Richard Zigeuner and Elvira Fehrenbach and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Heike Pohla

66 papers receiving 2.1k citations

Peers

Countries citing papers authored by Heike Pohla

Since Specialization

Citations

This map shows the geographic impact of Heike Pohla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Pohla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Pohla more than expected).

Fields of papers citing papers by Heike Pohla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Pohla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Pohla. The network helps show where Heike Pohla may publish in the future.

Co-authorship network of co-authors of Heike Pohla

This figure shows the co-authorship network connecting the top 25 collaborators of Heike Pohla. A scholar is included among the top collaborators of Heike Pohla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heike Pohla. Heike Pohla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer 2023 ·The Prostate ·Lili Wang, Chen Lyu, (unknown), Alexander Büchner, Elfriede Nößner, Heike Pohla	9
2	Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab 2023 ·Frontiers in Immunology ·Chen Lyu, (unknown), Lili Wang, Alexander Büchner, Heike Pohla	5
3	The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells 2022 ·Photodiagnosis and Photodynamic Therapy ·(unknown), Chen Lyu, (unknown), (unknown), Alexander Büchner, Herbert Stepp, Ronald Sroka, Heike Pohla	10
4	Diagnostic and Prognostic Role of miR‐192 in Different Cancers: A Systematic Review and Meta‐Analysis 2021 ·BioMed Research International ·Lili Wang, Yuhan Liu, Chen Lyu, Alexander Büchner, Heike Pohla	5
5	Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment 2012 ·International Journal of Hyperthermia ·(unknown), Ingo Drexler, (unknown), (unknown), Heike Pohla, Gerd Sutter, Elfriede Noeßner, Rolf D. Issels	1
6	Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study 2010 ·Gene Therapy ·Jörg Westermann, Anne Flörcken, Gerald Willimsky, Antje van Lessen, Joachim Kopp, (unknown), Korinna Jöhrens, Ansgar Lukowsky, C. Schönemann, Birgit Sawitzki, Heike Pohla, Ronald Frank, Bernd Dörken, D. J. Schendel, Thomas Blankenstein, Antonio Pezzutto	15
7	Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma 2009 ·Journal of Molecular Medicine ·(unknown), Elfriede Nößner, Bernhard Frankenberger, Christine S. Falk, Heike Pohla, Dolores J. Schendel	9
8	Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70 2007 ·Journal of Translational Medicine ·Anke Zobywalski, (unknown), Bernhard Frankenberger, Heike Pohla, Elisabeth Kremmer, Iris Bigalke, Dolores J. Schendel	112
9	Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response 2007 ·Journal of Translational Medicine ·Dominik Rüttinger, Natasja K. van den Engel, H. Winter, M. Schlemmer, Heike Pohla, (unknown), (unknown), Dolores J. Schendel, Bernard A. Fox, K.‐W. Jauch, Rudolf Hatz	21
10	Allogeneic retrovirally transduced, IL‐2‐ and IFN‐γ‐secreting cancer cell vaccine in patients with hormone refractory prostate cancer—a phase I clinical trial 2007 ·The Journal of Gene Medicine ·T. Brill, Hubert Kübler, (unknown), Falko Fend, Heike Pohla, J. Breul, R. Härtung, R. Paul, D. J. Schendel, Bernd Gänsbacher	19
11	The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients 2004 ·Der Urologe ·Dolores J. Schendel, Christine S. Falk, Bernhard Frankenberger, Elfriede Noeßner, Julia Schleypen, Heike Pohla	1
12	Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse 2000 ·Gene Therapy ·D. J. Schendel, Bernhard Frankenberger, (unknown), S Cayeux, (unknown), Gerald Willimsky, (unknown), Heike Pohla, T. Blankenstein	33
13	HSP expression in human leukocytes is modulated by endurance exercise 2000 ·Medicine & Science in Sports & Exercise ·Elvira Fehrenbach, F Passek, Andreas M. Nieß, Heike Pohla, Christof Weinstock, Hans-Herrmann Dickhuth, Hinnak Northoff	188
14	CYTOKINE MODULATION OF TH1/TH2 PHENOTYPE DIFFERENTIATION IN DIRECTLY ALLORESPONSIVE CD4+ HUMAN T CELLS1 1996 ·Transplantation ·Graham Pawelec, Arnika Rehbein, (unknown), (unknown), Heike Pohla	21
15	Human γδ Cells Are Resistant to Induction of Anergy but Not to Induction of Cell Death in Vitro 1995 ·Cellular Immunology ·Graham Pawelec, (unknown), Martina Boshell, (unknown), Arnika Rehbein, (unknown), Heike Pohla, Kurt Schaudt, David M. Sansom	4
16	Interleukin 10 is a human T cell growth factor in vitro 1995 ·Cytokine ·Graham Pawelec, Heike Pohla, (unknown), Arnika Rehbein, Kurt Schaudt, (unknown), (unknown)	11
17	Requirements for Stimulation or Anergy Induction in Alloreactive Human T Cell Clones 1994 ·Cellular Immunology ·Graham Pawelec, Hubert Kalbacher, Heike Pohla, Martina Boshell, (unknown), (unknown), Medi Adibzadeh, (unknown), David M. Sansom	5
18	Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. 1993 ·The Journal of Immunology ·Wilhelm Schwaeble, Wolfgang Dippold, Michaela Schäfer, Heike Pohla, Daniel E Jonas, (unknown), Eberhard Weihe, Hartwig P. Huemer, M. P. Dierich, K.B.M. Reid	53
19	The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells 1992 ·International Journal of Immunopharmacology ·(unknown), Heike Pohla, (unknown), (unknown), (unknown), Graham Pawelec	20
20	A physical map including a new class I gene (cda12) of the human major histocompatibility complex (A2B13 haplotype) derived from a monosomy 6 mutant cell line 1989 ·Genomics ·Jiannis Ragoussis, (unknown), Heike Pohla, Gerald Messer, Elisabeth H. Weiss, Andreas Ziegler	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact